Carnosine is a dipeptide formed of the amino acids β-alanine and histidine. Only a limited number of studies have examined the effects of carnosine on sympathetic nerve activation and anxiety. The present study was undertaken to determine the dose-related effects of carnosine on anxiety in the elevated T-maze test (ETM) with electrodermal activity (EDA). Carnosine was injected in three groups of rats with doses of 10 (low dose), 100 (medium dose) and 1000 (high dose) mg/kg i.p. Physiological saline was injected in the sham group. The anxiety scores of the rats were measured with ETM 20 minutes after injection. Then, SCL was measured. The decreased number of entries into the open arm (NEOA), the percentage of time spent in the open arm (% TSOA) and higher EDA [shown by skin conductance level (SCL)] indicate higher anxiety. The NEOA and % TSOA were lower in the high-dose group than in the other groups. SCL was lower in the medium-dose carnosine group than in the high-dose carnosine and sham groups. SCL was higher in the high-dose group than in the medium-dose and sham groups. Our results suggest that high-dose carnosine produced anxiety-like effects as assessed in the SCL and ETM. Medium-dose carnosine acted as an anxiolytic. The anxiety-related responses of carnosine depend on its dose-related effect.
Introduction
Carnosine, a naturally occurruing dipeptide, was first discovered by Gulewitsch and Amiradzibi in a meat extract in 1900 (24) . Carnosine (β-alanyl-l-histidine), which is a dipeptide formed of the amino acids β-alanine and histidine, is located in mammalian tissues including those in the central nervous system and in skeletal muscles (22) . Carnosine is an endogenously synthesized dipeptide which is present, in particular in the brain, cardiac muscle, kidney, stomach, olfactory bulb and in large quantities in skeletal muscle (18) . It is a multifunctional dipeptide with many roles including buffering (7), anti-oxidative properties (6) , the activation or inhibition of some enzymes such as phosphorylases (26) and sarcoplasmic reticulum calcium regulation (2) .
It is also a powerful anti-inflammatory dipeptide, presumably due to its anti-oxidant and anti-glycation properties (36) . Carnosine may prevent aging, Alzheimer's disease and diabetic complications. These conditions are associated with oxidative stress (21) .
Only a limited number of studies have examined the effects of carnosine on sympathetic nerve activation. Tanida and Niijima were studied the effect of different doses of carnosine on the blood pressure and renal sympathetic nerve activity (47) . As a result of their study, it was found that low-dose carnosine suppressed blood pressure and renal sympathetic nerve activity, while high-dose carnosine increased them. On the other hand, we could not find any study in the literature about the anxiogenic or anxiolytic effect of carnosine. In this study, we investigated the effects of different doses of carnosine on anxiety with electrodermal activity (EDA) and elevated T-maze (ETM).
One of the most widely used indices of the autonomic nervous system (ANS) in psychological research has been electrodermal activity (EDA), which is usually measured as skin conductance level (SCL) (10) . SCL reflects tonic levels of arousal (1, 8) . EDA has been utilized in research examining attention (33) , emotion (4), and psychopathology (44) . It is recorded as a change in skin potential or resistance of sweat gland reaction controlled by the sympathetic nervous system (SNS) (15) . The relationship between anxiety and sympathetic skin response (SSR), in other words SCL, has been widely studied. The results of studies on human subjects (shown by higher skin conductance level (SCL) (5, 23, 11) and animals (12, 13) indicate that anxious subjects have greater sweat gland activity.
However, data are limited in animals. These studies were conducted to assess the anxiolytic activities of some drugs (30, 41) , and to measure fear response, anxiety (12, 13) , arousal (11) , and stress (52) .
The elevated T-maze test, a well-established animal model of anxiety, is based upon the natural aversion of ro-dents to heights and open spaces and has been validated for rats (37) . Untreated animals usually spend more time in closed arms. The percentage of time spent in open arms is considered as an index of anxiety (38, 28, 45) . It is generally found that anxiolytic drugs increase the number of entries and time spent in open arms and these are decreased by anxiogenic drugs.
Certain pharmacological compounds can have dose-dependent treatment effects on anxiety-related behavior. The effects of carnosine on anxiety have not been well investigated. We know of only one study examining the relationship between anxiety and beta-alanine (formed in vivo by the degradation of carnosine) (32) . According to their study, beta-alanine-supplemented diet increased the percentage of time spent and entries in the open arms significantly in the elevated plus-maze test. This result suggested that chronic ingestion of beta-alanine-supplemented diet had an anxiolytic-like effect in mice. Beta-alanine has also been suggested to act as an inhibitory neurotransmitter, as it was reported to act on GABA and Gly receptors (51) . With respect to amino acids, GABA and its receptor agonists had an anxiolytic-and antidepressant effect (32) . Especially noradrenaline (NA) and 5-hydroxytriptamine (5-HT), which are thought to be deeply involved in the aetiology of depression and anxiety.
The present study was undertaken for the following reasons: a) to explore whether carnosine effect on anxiety or not b) to determine the dose-related effects of carnosine on anxiety on the ETM and with EDA, c) to determine the relationship between the behavioral scores of rats tested on the ETM and with EDA, d) which mechanisms may take role of carnosine on anxiety.
Materials and Methods

Subject
The experiments were carried out daily on 40 male Wistar rats at the 120-140 between 12.00-14.00 hrs. The rats weighed 280-300 g. The animals were acclimatized to the laboratory conditions for one week before the start of the experiment and were kept in a quiet temperature controlled room (22 ± 4 °C). A 12-hour light-dark cycle (7:00 to 19:00 p.m., 19:00 p.m. to 7:00) was provided. All rats were bred at the Hakan Çetinsaya Experimental and Clinical Research Center of Erciyes University and were fed with tap water and purina rodent chow. The experiments were carried out after receiving approval from the Committee on Ethics in Animal Experimentation at Erciyes University (no.08-12-86). All animal experiments were conducted at Erciyes University Faculty of Medicine, Department of Physiology in the Laboratory of Brain Dynamics.
Apparatus and procedure
Rats were divided randomly into sham and three experimental groups.
1-Sham group (n = 10): Physiological saline was injected. 2-CAR low-dose group (n = 10, 10 mg/kg): for preparation of the stock solution, 30 mg carnosine was dissolved in 10 ml physiological saline. Thus, 3 mg/ml carnosine was administered to each rat (27) .
3-CAR medium-dose group (n = 10, 100 mg/kg): for preparation of the stock solution, 300 mg carnosine was dissolved in 10 ml physiological saline. Thus, 30 mg/ml carnosine was administered to each rat (28).
4-CAR-high dose group (n = 10, 1000 mg/kg): for preparation of the stock solution, 3000 mg carnosine was dissolved in 10 ml physiological saline. Thus 300 mg/ml carnosine was administered to each rat (1).
Carnosine was obtained from Sigma (USA), it was and freshly prepared in saline and given as a single dose i.p. 30 min before testing.
Elevated T-Maze Test (ETM)
Rats were also submitted to an ETM, in order to determine if carnosine affected anxiety-related behavior (13) . 
Electrodermal Activity (EDA)
The physiological recordings took place in a dimly lit, electrically and acoustically shielded experimental room. EDA was measured using the MP30 system (MP30; Biopac Systems Inc., Santa Barbara, CA). EDA was recorded between the paw pads of both hindllimbs using 2 Ag/AgCl electrodes after the ETM. NaCl electrode (0.05 M) jelly was placed between the skin and the electrodes. The two electrodes were connected to the MP30 system. The signals coming from the skin were converted to digital signals by MP30 data acquisition unit and processed for off-line analysis on IBM-AT computer located in a separate room. Digital signals were stored in the computer for data analysis.
The mean of skin conductance (SC) was expressed as SCL [ln (µmho)/cm 2 per electrode area]. Two recordings were taken in 2 sections for all animals.
Tonic section was recorded over 2 min without any stimuli. The phasic section was recorded by giving 15 auditory stimuli. The stimuli were of 1-s duration, 1000 Hz tones with 50-ms rise and fall times. The sound chip of a comput-er produced the tones. They were amplified with an audio amplifier (Harvard). The intensity of the tones was 90 dB as measured by a sound level meter positioned at the approximate location of the rat's ear. The tones were presented against a 50-dB pink noise background. They occurred at pseudorandom intervals ranging from 30 s to 65 s and averaging 45 s. The mean SCL values were also calculated with off-line for phasic EDA. Values of phasic SCL were averaged from 10 rats per group during the all test period which applied 15 auditory stimuli
Procedure
The animals were conscious during the recordings. The rat received a single i.p. injection of carnosine or physiological saline. The ETM measurements were started 30 min after the injections. The ETM apparatus was wiped clean with a sponge and dried with cloth between tests. After ETM, SCL was recorded, without losing any time.
Statistical analyses
Values were expressed as means ± S.E. Data from the T-maze test and EDA were analyzed with the Kruskal-Wallis test for comparison of the 4 groups and the Mann-Whitney U test was used for comparison of 2 groups. Differences were considered to be significant with a probability less than 0.05. All the statistical analyses were performed using the SPSS 16.0 for Windows software.
Results
Effects of Carnosine on Rats in the T-Maze
The percentage of time spent and total time in the open arms, and the number of entries into the open and closed arms were measured in the T-maze test. Table 1 shows the performances of the groups in the T-maze. There were significant differences in all parameters according to Kruskal-Wallis test. The NEOA, NECA, TSOA, and % TSOA values of the sham group were significantly differenct from the CAR groups except for the medium-dose group.
The Table 2 indicates the mean SCL values in all groups. Fig. 1 shows an example phasic EDA recording of the carnosine groups. There were statistical differences among the groups for Tonic SCL (Kruskal-Wallis test, x 2 = 13.83, p = Tab. 1: Performances of the groups in the T-maze during 5 min period (mean ± SE). 0.003) and Phasic SCL (x 2 = 13.67, p = 0.003). Tonic and Phasic SCLs were statistically higher in the CAR high-dose group than in the sham group (respectively, z = −2.19, p = 0.02; z = −2.04, p = 0.04) and the CAR medium-dose group (respectively, z = −2.49, p = 0.013; z = −2.26, p = 0.02). Tonic and Phasic SCLs were statistically lower in the CAR medium-dose group than in the sham group (respectively, z = −2.49, p = 0.013; z = −2.26, p = 0.02) and CAR highdose group (respectively, z = −2.49, p = 0.013; z = −2.26, p = 0.02). These fi nding showed that CAR-high dose created an anxiogenic effect, while CAR-medium dose exhibited an anxiolytic effect (Fig. 2) .
Effects of Carnosine on Skin Conductance Level
NEOA
Tab. 2: Tonic and phasic SCL values of groups (mean ± SE).
SCL(µmho)
CAR-low dose (10 mg/kg) CAR-medium dose (100 mg/kg) CAR-high dose (1000 mg/kg) 
Discussion
Changes in sympathetic nerve activity may produce alterations in physiological functions. In this way, a small amount of CAR generates hypoglycemic, hypotensive, and lipolytic actions, when CAR is released from skeletal muscle (34) . The effects of carnosine on blood glucose, BP, lipolysis, and thermogenesis were dose-dependent or bell-shaped. According to the study of Nagai et al., studies (2012), optimal concentrations of CAR in the blood or brain may exist to determine the functions of CAR on these parameters. They claimed that physiologically there is no need to attain the highest CAR concentration in the blood or brain to realize its actions of CAR on these parameters (35, 34) .
In this study, we investigated the effects of three doses of carnosine (low, medium, high) on sympathetic skin response and anxiety with electrodermal activity and T-maze. We observed decreased anxiety and sympathetic skin response when medium doses of carnosine were injected but increased anxiety and sympathetic skin response when higher doses were injected.
Several studies related to the biphasic action of carnosine have been conducted. Jin et al. showed that long-term treatment with a low histamine diet enhances seizure development induced by PTZ kindling, while this effect can be reversed by simultaneous treatment with a high carnosine diet (25) .
Tanida et al. reported that L-carnosine, a dipeptide produced in skeletal muscle, has the biphasic effects on renal sympathetic nerve activity (RSNA) and blood pressure (BP). According to their study, thioperamide inhibited the suppressive effects of a low dose of L-carnosine on RSNA and BP and diphenhydramine eliminated the enhancement of the response caused by a high dose of L-carnosine on RSNA (47) . They suggested that that the effect of L-carnosine may be realized via a histaminergic neural function in the brain. It was also reported that carnosine (via histidine) may be metabolically transformed into histamine. In another study, carnosine has been proposed to provide a nonmast cell source of histidine in many histamine-rich tissues, available for histamine synthesis during periods of physiological stress (16) .
Tanida et al. studied the biphasic effect of carnosine on brown adipose tissue sympathetic nerve activity (BAT-SNA) in urethane-anesthetized rats (48) . The effect of a small or large amount of CAR on interscapular BAT-SNA was the opposite of its effect on white adipose tissue sympathetic nerve activity (WAT-SNA) (43) . A small amount of CAR (0.01 mg / 300 g BW, LCV) suppressed BAT-SNA, while a high amount of CAR (100 mg / 300 g BW, LCV) elevated BAT-SNA (48) . They suggested that excitation of BAT-SNA produces an increase in thermogenesis -mainly by using FFA -via activation of the adrenergic b-3 receptor and uncoupling protein 1 (UCP1) (17) .
They also examined the effect of CAR on body temperature in unanesthetized rats. The body temperature of rats was lowered by a small amount of CAR (0.01 mg / 300 g BW, LCV) and elevated by a high amount of CAR (100 mg / 300 g BW, LCV) (48) . They suggested that a smaller amount of CAR may decrease heat production in the brown adipose tissue (BAT) by suppressing BAT-SNA, whereas a higher amount of CAR increases heat production in BAT by elevating BAT-SNA. They found that these responses were time dependent, and it was possible that they were mediated by the master circadian clock SCN. They found that SCN lesions abolished both changes in autonomic neurotransmission (BAT-SNA) and body temperature, that the SCN was involved in the effect of CAR on BAT-SNA and thermogenesis. According to their study, further studies are required to establish whether the antioxidant and carnosinylation actions of CAR are implicated in the influence of CAR on lipid metabolism and thermogenesis (48) .
In our previous study we provided evidence for the biphasic action of carnosine on the dentate gyrus in vivo. We reported that, while lower doses of carnosine decreased population spike amplitude in the dentate gyrus, higher doses had an increasing effect on it. We considered that these findings might have occurred with different processes, such as soluble guanylyl cyclase inhibition or the conversion of carnosine into histamine (46) . In the light of these findings we thought that lower doses of carnosine would cause a decrease in intracellular Ca 2+ levels by chelate formation with sGS and that a higher dose would cause an increase in intracellular Ca 2+ levels by producing histamine-stimulated cAMP production. This explanation also seems to be valid for the SCL data observed in the present study.
Hori et al. examined the effects of intraduodenal (ID) injection of L-carnosine on splenic sympathetic nerve activity (splenic-SNA) in urethane-anesthetized rats. In their study, they applied low-dose carnosine. They found that ID injection of 3.3 mg/kg of body weight of L-carnosine significantly suppressed splenic-SNA, while 1 mg/mL of L-carnosine solution given as the only drinking water inhibited tumor proliferation. They suggested that splenic-SNA reduction increases the natural killer (NK) activity of splenic cells, which in turn elevates tumor immunity (22) . These results accord with our study.
There are no studies examining the effect of carnosine on anxiety in the literature. Murakami and Furuse investigated the antidepressant or anxiolytic-like effects of taurine and beta-alanine supplemented diet with ETM and forced swimming test. Taurine has functions as a neuromodulator and antioxidant, and beta-alanine (a taurine transporter inhibitor) has a role as a neurotransmitter in the brain (32) . Beta-alanine is formed in vivo by the degradation of carnosine and it is also the rate-limiting precursor of carnosine (49) . Murakami and Furuse studied behavioral changes and brain metabolites with chronic ingestion of a taurine-(22.5 mmol/kg diet) supplemented diet and beta-alanine-(22.5 mmol/kg diet) supplemented diet under acute stressful conditions. In the elevated plus maze, significant increases in the percentage of time spent in and entries in the open arms were observed in the beta-alanine-supplemented diet fed group compared with taurine-supplemented diet. The beta-alanine-supplemented diet increased carnosine (beta-alanyl-L-histidine) concentration in the cerebral cortex and hypothalamus. They suggested that taurine-supplemented diet had an antidepressant-like effect and the beta-alanine-supplemented diet had an anxiolytic-like effect (32). They did not give the carnosine directly to mice, so we could hot compare our results or our doses with their findings.
Some evidence supports the concept that histaminergic neurons influence anxiety-related behavior via H1 and H2 receptor activation (27, 53) . Serafim (39) . Since acetylcholine may modulate anxiety-related behaviors (9), one may expect that this response to the highest doses of antagonist CPA is mediated through changes in acetylcholine levels. In contrast, other studies have reported an anxiolytic response mediated by H1 receptors in rats and mice (40) . The reported discrepancies could be related to experimental differences among the many factors that appear to influence the aversion to open arms, such as the time of day at which testing occurs (20) and the levels of illumination in the testing room (19) .
In conclusion, this is the first study to investigate the effects of carnosine on anxiety and sympathetic skin response. Our results provide evidence for the biphasic action of carnosine on anxiety and sympathetic skin response, while lower doses of carnosine decreased anxiety, higher doses had an increasing effect on it. Although we considered that these findings might have occurred with its conversion into histamine, its anti-oxidant and anti-glycation properties or act on GABA and Gly receptors. Further studies are needed to explain the exact mechanism carnosine has on anxiety and sympathetic activity. After further studies, we are suggesting, carnosine may be important drug for anxiety treatment.
